Front
Front作者机构:不详
出 版 物:《Acta Pharmaceutica Sinica B》 (药学学报(英文版))
年 卷 期:2020年第10卷第4期
页 面:567-567页
核心收录:
学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
主 题:Front breast cancer cells BRCA1-deficient
摘 要:BRCA1-deficient breast cancer cells are selectively vulnerable to classⅠhistone deacetylase(HDAC)inhibitors via the mechanism,whereby HDAC inhibition enhanced the expression of the cellular pro-oxidant genes,causing the reactive oxygen species(ROS)-mediated DNA damage in cells.This effect induced preferential apoptosis in BRCA1-/-breast cancer cells where DNA repair system is compromised.